Abstract: Granulocytic anaplasmoses represent a group of emerging tick-borne infectious diseases caused by the obligate intracellular gram-negative bacterium, Anaplasma phagocytophilum (Rickettsiales) that infects granulocytes. It has been known as a ruminant pathogen in Europe since 1932, however, recently it has emerged as a pathogen of humans and domestic animals such as dogs and horses in the Northern Hemisphere, including United States and Europe. Rodents and game animals (especially deer) are presumed to play a crucial role in the maintenance of A. phagocytophilum in natural foci and serve as competent reservoirs. Up to now, the presence of bacterial DNA has been confirmed by molecular methods in a number of domestic and wildlife animals. Circulation of several genotypes has been confirmed in natural foci but the vector competence and the host spectrum involved in its circulation is still under investigation. Human granulocytic anaplasmosis (HGA) typically occurs in spring or summer and clinical manifestations range from mild or self-limiting to severe disease, especially in elderly patients with up to 50% requiring hospitalization and 7% intensive care. So far, no confirmed A. phagocytophilum infections of humans have been reported in Slovakia despite the fact that the presence of anti-anaplasma antibodies has been detected in investigated patients sera. This fact could be explained by non-specific clinical signs of the infection or lack of information in physicians and underdiagnosed or misdiagnosed cases. The purpose of this review is to present biology, ecology and life cycle of A. phagocytophilum and introduce clinical symptoms, diagnosis and treatment of the infection caused by this pathogenic bacterium.
Introduction
The tick-transmitted bacterium Anaplasma phagocytophilum is the causative agent of granulocytic anaplasmosis, an infection of medical and veterinary importance that is widely distributed across the temperate zones of the Northern Hemisphere. This febrile illness is accompanied by non-specific, flu-like clinical signs, which especially in older or immunocompromised patients can be fatal. The main vectors are ticks of the Ixodes ricinus (L., 1758) complex. Rodents and wild ungulates are considered as the competent reservoir hosts.
Anaplasma phagocytophilum is a small (approximately 0.2-1.0 µm in diameter) coccobacillary bacterium with gram-negative cell wall that replicates within a host cell vacuole to form a microcolony called morula (Rikihisa 1991; Chen et al. 1994) . It infects cells derived from mammalian bone marrow, predominantly cells of the myeloid lineage (Dumler et al. 2001) . In infected host cells two distinct morphologic forms may be detected: dense-core (DC) forms (0.4-0.6 µm in diameter), with a centrally or eccentricallyplaced chromatin strands, and reticulate cell (RC) forms (0.4-0.6 µm × 0.7-1.9 µm) that contain a homogeneous loose matrix of chromatin strands. In acute phase blood smears RC and DC cells can be present solo, or like mulberry-like morulae. Morulae range in size up to 4.0 µm in diameter and contain 1 to 40 organisms of uniform or mixed cell types (Dumler et al. 2005) .
Taxonomy of the family Anaplasmataceae
Anaplasma phagocytophilum belongs to the family Anaplasmataceae that includes following genera: Anaplasma, Ehrlichia, Neorickettsia and Wolbachia (Dumler et al. 2001) . 'Candidatus Neoehrlichia mikurensis' found in Ixodes ovatus Neumann, 1899 ticks and in wild rodents in Japan formed a separate clade in this family (Kawahara et al. 2004 ). Ehrlichia-like bacteria "Schotti variant" and Ehrlichia spp. "Rattus strain" that were revealed in Ixodes ricinus (L., 1758) and I. persulcatus Schulze, 1930 also belong into this clade (Schouls et al. 1999; Sphynov et al. 2006; Špitalská et al. 2006) .
Three organisms within the family Anaplasmataceae, Ehrlichia phagocytophila, Ehrlichia equi and the HGE agent, share at least 99.1% nucleotide sequence similarity in their 16S rRNA genes, have identical GroEL amino acid sequences and are closely related on the basis of antigens analysed by indirect fluores-cent antibody test and therefore were unified into a single species, Anaplasma phagocytophilum (Dumler et al. 2001) . Other species from the genus Anaplasma are important veterinary pathogens. Anaplasma marginale is the most prevalent tick-borne pathogen causing bovine anaplasmosis in cattle worldwide with significant economic losses, especially in tropical and subtropical areas. It invades erythrocytes and leads to extravascular hemolysis. Over 20 species of ticks have been recorded as vectors of this pathogen worldwide (Kocan et al. 2004) . Currently, Dermacentor spp. are the major tick vectors of A. marginale in the USA (Stiller et al. 1989) , while in tropical and subtropical areas Rhipicephalus (Boophilus) microplus (Canestrini, 1888) and Rhipicephalus annulatus (Say, 1821) are the main vectors of the bacterium (Scoles et al. 2007 ). The vectorial capacity of tick species for A. marginale in Europe has not been well defined. Despite differences in morphology, distribution, virulence, and localization within infected erythrocytes, Anaplasma centrale appears to be closely related to A. marginale as shown by comparision of protein and antigenic composition (Nakamura et al. 1991) . It infects erythrocytes and causes mild form of anaplasmosis in cattle (Bock et al. 2003) . Anaplasma ovis infects sheep, goats and wild ruminants (Krier & Ristic 1963; Zaugg 1988; Kuttler 1984; De La Fuente et al. 2006) . Anaplasma bovis is a monocytotropic bacterium that infects cattle and perhaps other ruminants (Dumler et al. 2001 ). Anaplasma platys is infective for dogs and develops within blood platelets. It is the etiologic agent of canine infectious cyclic thrombocytopenia, but infected dogs are usually asymptomatic (Harvey et al. 1978) .
The genus Ehrlichia involves E. chaffeensis, E. canis, E. ewingii, E. muris, E. ovina and E. (formerly Cowdria) ruminantium. Ehrlichia chaffeensis infects predominantly mononuclear phagocytic cells. Whitetailed deer is an important source of blood for adult and immature stages of Amblyomma americanum L., 1758, the principal vector of this pathogen. Ehrlichia chaffeensis causes human monocytic ehrlichliosis (HME), an emerging tick-borne zoonosis that was discovered in the United States in 1986 (Maeda et al. 1987) . Ehrlichia canis is a rickettsial gram-negative bacterium responsible for canine monocytic ehrlichiosis (CME) (De Castro et al. 2004) , and is transmitted by ticks of the genus Rhipicephalus (Lewis et al. 1977) . The murine pathogen, E. muris was initially isolated in 1983 from the spleen of a wild mouse (Eothenomys kageus Imaizumi, 1957) in Japan (Kawahara et al. 1993) . It is closely related to E. chaffeensis, but the pathogenic role of E. muris for humans is yet unknown (Kawahara et al. 1993) . This bacterium has recently been isolated from Apodemus flavicollis (Melchior, 1834) and feeding I. ricinus ticks from Central Slovakia (Smetanová et al. 2007) . Amblyomma americanum and Ixodes spp. ticks have been defined as vectors (Thomas et al. 2009 ). Ehrlichia ewingii causes granulocytic ehrlichiosis primarily in dogs or immunocompromised patients in the United States (Buller et al. 1999 ).
Ecology of A. phagocytophilum
Competent vectors of A. phagocytophilum are hard ticks (Ixodida) that are able to acquire infection when taking a blood meal from an infected animal and transmit the bacterium to another hosts during the feeding in the next stage. In the United States the principal vectors are black-legged ticks Ixodes scapularis Say, 1821 and I. pacificus (Cooley et Kohls, 1943) (Richter et al. 1996; Reubel et al. 1998) , while in Europe I. ricinus has been found to be the main vector (Strle 2004) . Anaplasma phagocytophilum has been also associated with other ticks, such as Dermacentor spp. (De La Fuente et al. 2005) and Rhiphicephalus sanguineus (Latreille, 1806) (Alberti et al. 2005) , the epidemiological importance of these findings remains to be determined. Nidicolous ticks like I. trianguliceps (Birula, 1895) in Europe rarely bite humans and are likely involved as vectors for maintaining enzootic infectious cycles (Bown et al. 2009 ).
The prevalence of A. phagocytophilum infection in I. ricinus ticks varies geographicaly and depends on the presence of competent reservoir hosts. In Europe, prevalence in ticks ranges from 0.4% to 66.7%, and the bacterium has been more frequently detected in adult ticks than in nymphal stages (Blanco & Oteo 2002) . This fact can be explained by the natural cycles of A. phagocytophilum in which mainly large wild mammals are considered as potential reservoirs for this pathogen. Studies in Slovakia demonstrated DNA evidence of A. phagocytophilum in 2.8% up to 30% of questing I. ricinus ticks (Derdáková et al. 2003; Kocianová et al. 2008a) .
Rodents and ungulates are considered competent reservoir hosts for A. phagocytophilum (Bown et al. 2006) . Wild rodents, in particular Apodemus sylvaticus (L., 1758) (wood mouse), A. flavicollis (yellow-necked mouse), A. agrarius (Pallas, 1771), and especially Myodes glareolus (Schreber, 1780) (bank vole) have been implicated as reservoirs of A. phagocytophilum in Europe (Brouqui 1999; Liz et al. 2000; Štefančíková et al. 2008) . Sheep, red deer (Cervus elaphus L., 1758) and roe deer [Capreolus capreolus (L., 1758)] are also naturally infected and are considered reservoirs (Liz et al. 2002; Ogden et al. 2002; Alberdi et al. 2004; Šte-fanidesová et al. 2008) . In Europe, A. phagoyctophilum DNA has also been detected by PCR in a great variety of domestic and wild animals, such as wild boar (Sus scrofa L., 1758), red fox (Vulpes vulpes L., 1758), fallow deer [Dama dama (L., 1758)], chamois [Rupicapra rupicapra (L., 1758)], hare (Lepus europaeus L., 1758), brown bear and many others (Hulínska et al. 2004; Šte-fančíková et al. 2005; Víchová et al. 2009 ). Levin et al. (2002) confirmed reservoir competence of medium-sized mammals, like rabbits, raccoons, squirrels, and skunks for the agent of HGA that become naturally infected and are capable of transmitting the infection to feeding ticks. Forest birds have not been considered as competent reservoir of A. phagocytophilum (Skotarczak et al. 2006 ).
In nature, several strains of A. phagocytophilum capable of causing disease in sheep, cattle, horses, dogs, cats and humans have been found. Biological and ecological differences between these strains (or genetic variants) clearly exist; including DNA sequences, antigenic diversity, reservoir competence, hosts pathogenicity, vector competence and geographical distribution. Different A. phagocytophilum variants show disparities also in clinical severity and disease manifestation. Recent studies indicate that vectors and hosts may be infected with several variants simultaneously and that these variants behave differently in the mammalian host. One of the most frequently used gene for phylogenetic studies is 16S rRNA gene because of a slow rate of mutation in its variable intragenic region and the availability of a large sequence database in GenBank for sequence comparison (Stuen 2007) . Chen et al. (1994) amplified a portion of 16S rRNA gene from the acutephase blood of a patient with granulocytic anaplasmosis. The 16S rRNA sequence of the human granulocytic anaplasmosis agent (AP-ha variant) showed only two nucleotide differences from E. phagocytophila (causing a tick-borne fever in ruminants) and three nucleotide differences from E. equi (causing granulocytic anaplasmosis of horses). Massung et al. (2002) amplified a portion from the 5' region of the 16S rRNA gene to identify granulocytic ehrlichiae in tick and wildlife samples. In blood samples from white-footed mice and ticks besides APha also the AP-variant 1 was determined, previously described in ticks in Rhode Island and deer in Maryland and Wisconsin, that differs from AP-ha by two nucleotides. Rhode Island samples from I. scapularis ticks, white-footed mice and chipmunks contained A. phagocytophilum variants as well as AP-ha, some ticks showed sequences corresponding to variant 1, and the rest of ticks had a novel sequence differing from AP-ha by two nucleotides and from variant 1 by four nucleotides (hereafter called AP-variant 2). DNA sequences from Rhode Island chipmunks represented novel variant sequences, each differing from AP-ha by a single nucleotide (AP-variants 3 and 4).
Human infective AP-ha variant of A. phagocytophilum is maintained in white-footed mice. Genovariant AP-1 detected in white-tailed deer and I. scapularis ticks is not infectious in mice, hamsters, gerbils, and has not been associated with human disease. White-tailed deer (Odocoileus virginianus Zimmermann, 1780) appears to serve as a natural reservoir for AP-variant 1 and goats have been competent reservoirs in experimental conditions (Massung et al. 2006 ).
Massung's data suggest that AP-Variant 1 is restricted to ruminant species (especially deer) and represents a lineage distinct from AP-ha which infects humans and numerous other mammals and probabaly circulates independently from the human-infective APha strain of A. phagocytophilum. Pathogenic potentials of ruminant strains from Europe and North America appear to differ dramatically. American AP-Variant 1 strain has evolved into a less pathogenic form than the European ruminant strains (Massung et al. 2006) .
In Europe, the epidemiology of A. phagocytophilum infection appears to be quite different from that in the United States. Although far fewer human cases have been reported, infections in livestock are common and represent a large financial burden to the industry (Foley et al. 2001 ). Surveys of strains infecting European livestock and wild-living ungulates have found numerous 16S rRNA sequence types, including AP-ha and AP-variant 1. European strains revealed considerably greater diversity than those seen among U.S. strains alone (Barbet et al. 2006) . In Central Bohemia, seroprevalence, infection rate and genetic variants of A. phagocytophilum in a variety of large mammals were studied. DNA of the bacterium was detected in blood samples of all ruminat species. Four genetic variants segregated from one another by species barriers were distinquished based on partial 16S rRNA sequences in extracts of DNA of A. phagocytophilum from samples of red deer, roe deer and mufflon (Zeman & Pecha 2008) . Zeman & Jahn (2009) analysed selected partial sequences of 16S rRNA, groESL, msp4 and ankA genes with the use of tentative multilocus typing scheme to characterize the strains causing equine granulocytic anaplasmosis (EGA). Identification of alleles characteristic of equine strains of A. phagocytophilum and distinquishing of two unique genetic variants infecting horses in the Czech Republic were achieved. These two novel genetic variants appeared to be phylogenetically closer to the strains reported as causing human disease in Slovenia than to strains thus far isolated from other European EGA cases. Moreover, in Austria presence of two genetic lineages in I. ricinus ticks as well as one variant in red and roe deer have been confirmed (Polin et al. 2004) .
Anaplasma phagocytophilum has been detected in I. ricinus ticks from southwestern Slovakia first in 2002 (Špitalská & Kocianová 2002) . Subsequently, the pathogen has been isolated from spleens of Apodemus flavicollis and Myodes glareolus from the same part of the country (Špitálska & Kocianová 2003) . Ixodes ricinus ticks from Central Slovakia were also positive for A. phagocytophilum (4.4%) (Smetanová et al. 2006) and the presence of the pathogen has been confirmed also in red deer (14.1%) and roe deer (18.2%) in Central Slovakia (Štefanidesová et al. 2008) . We have confirmed the presence of A. phagocytophilum in red deer, roe deer, fallow deer, wild boars, chamois, as well as in brown bear (Ursus arctos L., 1758) (Víchová et al. 2009 ). The genetic variabily of these strains is further investigated. In humans, 25% seroprevalence of antianaplasma IgG antibodies in tick-exposed individuals has been detected from Central Slovakia (Kocianová et al. 2008b) .
Despite the fact that 16S rRNA gene is appropriate for the basic molecular identification of the bacterium, there are many more appropriate gene-candidates (for instance ankA, groESL) that allow tracking of prospective differences among A. phagocytophilum strains circulating in natural foci.
Granulocytic anaplasmosis in humans and animals
Anaplasma phagocytophilum resides within neutrophils of numerous domestic animals, wildlife, and humans. Canine anaplasmosis caused by A. phagocytophilum varies from a subclinical infection to an acute febrile condition accompanied by anorexia and lethargy. Moreover, central nervous system dysfunction and lameness have been recorded in dogs. Based on reports to date, A. phagocytophilum appears to cause a less severe disease in dogs than does the infection with E. canis, E. chaffeensis, or E. ewingii. Lethargy, accompanied by fever, appears to be sustainly documented. Although most dogs have a mild thrombocytopenia, anaemia is uncommon and changes in the leukocyte numbers are variable. Serologic assessments indicate that many clinically healthy dogs have elevated titres to A. phagocytophilum, which suggests that cases may be subclinical or the disease may be underdiagnosed (Foley et al. 2001) . Equine anaplasmosis is a seasonal disease of horses first reported in 1969. Clinical signs in horses include high fever, depression, partial hypophagia, anorexia, limb oedema, petechiatiae, ataxia, and reluctance to move. Haematologic changes include leukopenia, thrombocytopenia, icterus, anaemia, and inclusion bodies, principally in neutrophils and occasionally in eosinophils. Diagnosis is made by clinical signs and observing characteristic morulae in a blood smear with standard Wright's stain. Mortality is low unless secondary infection develops or injury occurs as a result of incoordination (Madigan 1993) .
Since the first published human cases of granulocytic anaplasmosis in the U.S.A. in 1994 (Chen et al. 1994 ) and in 1997 in Europe (Petrovec et al. 1997) , presence of anti-anaplasma antibodies was detected in many European countries with seroprevalence ranging from 2% to 30%, depending on the applied method and the study group (Strle 2004) . Due to non-specific clinical signs and lack of information about HGA in physicians, the number of confirmed clinical cases across Europe is relatively low (Blanco & Oteo 2002; Strle 2004) . The incubation period of HGA following a tick bite ranges from 5 to 21 (median 11) days. Most cases occur between April and October, peaking in July. Infection is for healthy individuals usually mild, but older persons and patients who are immunocompromised by other infection agents or medications may develop an acute, influenza-like illness characterized by acute high fever (>38 • C) or prolonged subfebrile stage, rigors, generalized myalgias, arthralgias and severe headache (Dumler et al. 2005) . Local skin reactions at the site of the tick bite have not been described and nonspecific skin rashes have been reported only occasionally. This condition was associated with HGA and coinfection with spirochetes from the Borrelia burgdorferi s.l. complex (Loebermann et al. 2006) . No chronic forms of the infection have been documented in Europe, although A. phagocytophilum DNA has been demonstrated in the convalescent blood of one patient on day 22 after onset of the infection and 16 days after defervescence (Arnez et al. 2001) . In some fatal cases of HGA death resulted from opportunistic fungal or viral infections or hemorrhage that occurred immediately after infection. This suggests that an intact immune system is important for recovery from HGA (Dumler et al. 2005) .
Whole blood and serum samples of foresters and hunters from different areas of Slovakia revealed 5.7% seroprevalence of anti-anaplasma antibodies. The blood from a 54 years old hunter from Ružomberok gave positive PCR result for of A. phagocytophilum DNA. Subsequent sequencing of the 16S rRNA gene revealed the presence of A. phagocytophilum. He had been bitten by ticks few months before the blood was drawn. Two weeks after the tick attachement he suffered from strong headache, long-lasting subferility, arthralgia, myalgia and intensive exudation. The IFA test for A. phagocytophilum specific IgM and IgG antibodies was negative (Nováková et al. 2010) .
As the clinical manifestations and laboratory findings of HGA are nonspecific, selection of competent diagnostic tools is needed to detect the infection in time. Anaplasma phagocytophilum morulae can be visualized in blood smears stained with Romanowsky, MayGrünwald or Giemsa. However, the infection rate in peripheral blood neutrophils may vary from 0.5% to 73% (Rikihisa 1991) and in spite of detection of morulae, the species involved can not be specified. Furthermore, the detection of morulae depends on the experience of the microscopist and the duration and stage of the illness. It can usually be seen during the acute fever period of the infection, but false-negative results are possible (Blanco & Oteo 2002) . Anaplasma phagocytophilum has been successfuly cultured in HL-60 cells, a promyelocytic leukemia cell line. Culture is the most definitive method to confirm diagnosis of HGA during the acute phase and prior to effective antimicrobial treatment (Aguero-Rosenfeld 2003) . Detection of A. phagocytophilum DNA by PCR method represents a sensitive and rapid diagnostic tool and is useful for detection, identification and phylogenetic analysis of the bacterium from blood, skin biopsy specimen and ticks (Blanco & Oteo 2002) . Several primer sets have been used to amplify specific nucleic acid sequences of A. phagocytophilum, but 16S rRNA gene analysis has become the gold standard for phylogenetic classification of bacteria species. PCR has a sensitivity of about 75-80% compared with culture during the acute phase of the illness (Aguero-Rosenfeld 2003) . According to a declaration of the WHO (2008), confirmation of HGA requires A. phagocytophilum isolation from blood, and/or identification of morulae in granulocytes, and/or positive PCR results with subsequent sequencing of the amplicons to demonstrate specific anaplasmal DNA. Seroconversion, or at least a fourfold increase in antibody titers to A. phagocytophilum were also used as criteria for confirmed HGA (Brouqui et al. 2004) .
Patients often show a robust immune response to A. phagocytophilum. In the absence of treatment, detecable IgM levels generally rise 3 to 5 days post infection or 24 hours after the initial onset of fever, drop again to undetectable levels in about 30 to 60 days. IgG antibodies are detectable about 7 to 10 days post infection, peaking on day 14 to 21 and persist approximately a year. Seropositivity rates for both IgM and IgG antibodies tend to peak in July, August and September (Bakken et al. 1997) . Fluorescent detection of antibodies is the most common diagnostic technique. Due to potential cross-reaction with E. chaffeensis and other rickettsial agents false-positive results are possible (Blanco & Oteo 2002) .
In some cases, symptoms abate even without the use of antibiotics (Misic-Majerus et al. 2000; Arnez et al. 2001) . In any case, empirical therapy should start without waiting for microbiological confirmation. Many antibiotics, including doxycycline, rifampin and fluoroquinolones (such as ciprofloxacin, ofloxacin, levofloxacin, and trovafloxacin), have demonstrated significant activity against the HGA agent (Blanco & Oteo 2002) .
Conclusion
Since the first description of the prototype of Anaplasma phagocytophilum, the agent responsible for tickborne fever, in Scotland in 1932, through the discovery of a similar granulocytic agent causing disease in horses in the USA in 1969, and the detection of the agent evoking similar disease in dogs in the USA in 1971, many studies have been conducted in the field of granulocytic anaplasmosis research. Originally, A. phagocytophilum was thought to be of veterinary importance only, until the isolation of the agent from a human patient in USA (1994) and Europe (1997) . At present, it is accepted that A. phagocytophilum shows evident intraspecific heterogenity and the circulation of several distinct variants, infecting humans and a great variety of domestic and wild animals, has already been confirmed in America, Asia and Europe. Recently, more efforts are being implemented into the research of natural diversity of A. phagocytophilum in order to better understand ecology, epizootiology and epidemiolgy of the pathogen and ultimately, to estimate the environmental health hazard for humans and animals.
